Recurrent Sinopulmonary Infection and Impaired Antibody Response to Bacterial Capsular Polysaccharide Antigen in Children with Selective IgG-subclass Deficiency
Overview
Authors
Affiliations
We studied 20 children with recurrent sinopulmonary infections and serum IgG levels within the normal range, who had selective IgG-subclass deficiency. Twelve of the children were IgG2 deficient, five were IgG3 deficient, and three were deficient in both IgG2 and IgG3. IgA deficiency was present in 3 of the 20 patients. In the children with IgG2 deficiency, serum antibody concentrations to the capsular polysaccharide of Hemophilus influenzae type B (Hib) were significantly lower than those in age-matched controls, both before and after immunization with the Hib capsular polysaccharide antigen, which elicits antibody predominantly of the IgG2 subclass. In contrast, their serum antibody titers to the tetanus and diphtheria toxoid protein antigens, which elicit antibody predominantly of the IgG1 subclass, were normal in comparison with those of age-matched controls. These results suggest that impairment of the antibody response to specific microbial antigens predisposes patients with selective IgG-subclass deficiencies to recurrent infections. Thus, as an aid in determining therapy, children with recurrent infections and normal total serum IgG should be evaluated for this condition.
Fasshauer M, Dinges S, Staudacher O, Voller M, Stittrich A, von Bernuth H Front Pediatr. 2024; 12:1386959.
PMID: 38933494 PMC: 11203071. DOI: 10.3389/fped.2024.1386959.
Unninayar D, Shea B, Cameron D, Cowan J BMJ Open. 2023; 13(2):e064307.
PMID: 36759034 PMC: 9923280. DOI: 10.1136/bmjopen-2022-064307.
Deghmane A, Taha M Microorganisms. 2021; 9(3).
PMID: 33668334 PMC: 7996259. DOI: 10.3390/microorganisms9030467.
Specific Antibody Deficiency in Adult Patients With IgG or IgG Subclass Deficiency.
Kim J, Jang J, Lee S, Yang E, Jang S, Jung K Allergy Asthma Immunol Res. 2021; 13(2):271-283.
PMID: 33474861 PMC: 7840874. DOI: 10.4168/aair.2021.13.2.271.
Immunoglobulin G2 Antibody as a Potential Target for COVID-19 Vaccine.
Andualem H, Kiros M, Getu S, Hailemichael W Immunotargets Ther. 2020; 9:143-149.
PMID: 33062618 PMC: 7532904. DOI: 10.2147/ITT.S274746.